comprehensive -WSS

comprehensive

author：fashion 2025-09-03 03:45:36 - browse：65

Illustration of a doctor and patient. The shadow behind the doctor displays 0s and 1s for artificial intelligence. –– health tech coverage from STAT — Molly Ferguson for STAT

The world’s largest technology companies are racing to build generative AI into every corner of health and medicine.

Microsoft has formed an alliance with the electronic health records vendor Epic to wire the technology into dozens of health software products. Google is infusing it into tools used by hospitals to collect and organize data on millions of patients. Not to be outdone, Amazon has unveiled a service to help build clinical note scribes, and is separately working to embed generative AI in drug research and development.

All of this has unfolded faster than federal regulators could blink — or answer questions about how the technology should be tested and evaluated, whether it will help or hurt patients, and how it will impact privacy and the use of personal data.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： AstraZeneca, Daiichi breast cancer treatment succeeds in trial

WSS

Medical student insurance fails on mental health care coverage

Emergency workers more likely to restrain Black patients: study

Lecanemab for Alzheimer's is coming. Is the health system ready?

Drug for rare kidney disease narrowly misses mark in clinical trial

Biotech stock slump in 2023: awaiting the turnaround

Second xenotransplant done with gene

explore

comprehensive

focus

Cancer drug shortages should be causing more outrage

HCA discloses massive data breach affecting 11 million patients

Sports medicine is finally prioritizing gender equality

Thermo Fisher plant for manufacturing gene therapies to expand

The high cost of giving birth even with insurance

How Vertex's cystic fibrosis drug is changing patients' lives

Medicare proposal to cover medical devices draws a mixed reaction

HCA discloses massive data breach affecting 11 million patients

Virginia high school admissions case could be legal follow

Leqembi, other new Alzheimer’s drugs require better biomarkers

hotspot

Leqembi, other new Alzheimer’s drugs require better biomarkers

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

What to know about OceanGate, the company behind the missing Titanic submersible

A new study sees potential in DNA sequencing of infants

Drug for rare kidney disease narrowly misses mark in clinical trial

CDC advisers recommend seasonal use of Pfizer RSV shot

Wikipedia

leisure time

entertainment

explore